EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biodistribution and radiation dosimetry of the PDGFRβ targeting PET tracer [68Ga]Ga-ATH001

Mark Lubberink, Talakad G Lohith, Zoltan Derdak, Paul Wilkens, Emilia Palmér, Alexandra Ramolli, Mélodie Ferrat, Thuy A Tran, Bogdan Mitran, Ayman Abouyzayed, Lars Johansson, Haakan Wennbo und 3 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2026-11 · 53 (13) · 8508-8513

DOI: 10.1007/s00259-026-08167-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 08.09.2026. Verfasst von Mark Lubberink und 14 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging and Medical Physics, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Gallium Radioisotopes, Receptor, Platelet-Derived Growth Factor beta, Radiopharmaceuticals. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uppsala University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose [ 68 Ga]Ga-ATH001 is an Affibody molecule targeting PDGFRβ in development as a Positron Emission Tomography (PET) tracer for non-invasive imaging of active fibrosis. Here we present first-in-human [ 68 Ga]Ga-ATH001 biodistribution and radiation dosimetry data.

Methods

Radiation dosimetry of [ 68 Ga]Ga-ATH001 was evaluated in healthy participants (n = 3) and participants with metabolic dysfunction-associated steatohepatitis (MASH) (n = 3). Each participant was intravenously administered ~ 2.5 MBq/kg [ 68 Ga]Ga-ATH001 and imaged by whole-body PET for up to 3 h post-injection. Absorbed dose coefficients and effective doses according to ICRP 103 were calculated using IDAC DOSE 2.1.

Results

The effective dose of [ 68 Ga]Ga-ATH001 was 0.028 ± 0.002 mSv/MBq with kidneys as the dose-limiting organ. Administration of a target dose of 2 MBq/kg would result in a sex-averaged effective dose of 4.1 mSv. Subjects tolerated the tracer administration well. Conclusion [ 68 Ga]Ga-ATH001 demonstrates a dosimetry and safety profile that supports further clinical development as a repeatable, non-invasive PET marker of active fibrosis in tissue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyGallium RadioisotopesReceptor, Platelet-Derived Growth Factor betaRadiopharmaceuticalsHumansTissue DistributionMaleFemaleRadiometryAdultMiddle Aged

Stichwörter der Autor:innen

DosimetryFibrogenesisFibrosisPDGFRβPET

Substanzen

Gallium RadioisotopesReceptor, Platelet-Derived Growth Factor betaGallium-68Radiopharmaceuticals

Autor:innen und Institutionen

  • Molecular Imaging and Medical Physics, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Takeda Development Center Americas, Inc, Cambridge, MA, USA.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Department of Nuclear Medicine and Medical Physics, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Theranostics Trial Center, Karolinska Institutet, Stockholm, Sweden.

Förderung

  • Uppsala University

Zitieren

APA

Lubberink, M., Lohith, T. G., Derdak, Z., Wilkens, P., Palmér, E., Ramolli, A., Ferrat, M., Tran, T. A., Mitran, B., Abouyzayed, A., Johansson, L., Wennbo, H., Rorsman, F., Vessby, J., & Eriksson, O. (2026). Biodistribution and radiation dosimetry of the PDGFRβ targeting PET tracer [68Ga]Ga-ATH001. European Journal of Nuclear Medicine and Molecular Imaging, 53(13), 8508-8513. https://doi.org/10.1007/s00259-026-08167-9

Vancouver

Lubberink M, Lohith TG, Derdak Z, Wilkens P, Palmér E, Ramolli A, et al. Biodistribution and radiation dosimetry of the PDGFRβ targeting PET tracer [68Ga]Ga-ATH001. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(13):8508-8513. doi:10.1007/s00259-026-08167-9

BibTeX
@article{Lubberink2026,
  author = {Lubberink, Mark and Lohith, Talakad G and Derdak, Zoltan and Wilkens, Paul and Palmér, Emilia and Ramolli, Alexandra and Ferrat, Mélodie and Tran, Thuy A and Mitran, Bogdan and Abouyzayed, Ayman and Johansson, Lars and Wennbo, Haakan and Rorsman, Fredrik and Vessby, Johan and Eriksson, Olof},
  title = {Biodistribution and radiation dosimetry of the PDGFRβ targeting PET tracer [68Ga]Ga-ATH001},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {13},
  pages = {8508--8513},
  doi = {10.1007/s00259-026-08167-9}
}
Kostenlos starten →